Preferred Label : HER-2 positive breast cancer;

Query (CISMeF) : cancer du sein HER2 positif.ti ou (tumeurs du sein.mc et (gènes erbB-2.mc ou récepteur erbB-2.mc));

PubMed query (by CISMeF) : %22her-2 positive breast cancer%22[TIAB] OR (%22breast neoplasms%22[MH] AND (%22genes, erbB-2%22[MH] OR %22receptor, erbB-2%22[MH]))

PubMed query (by CISMeF) : %22Breast Neoplasms%22[MH] AND (%22Genes, erbB-2%22[MH] OR %22Receptor, erbB-2%22[MH])

Details


Main resources

You can consult :


https://pgtmsite.files.wordpress.com/2024/01/trastuzumab-emtansine_position-preliminaire_final-27oct2014.pdf
2014
Canada
drug information
Metastatic Malignant Neoplasm in the Breast
trastuzumab
neoplasm, malignant
HER2/Neu Positive
HER2-Positive Breast Carcinoma
breast neoplasms
trastuzumab emtansine
Trastuzumab Emtansine
HER-2 positive breast cancer
Ado-Trastuzumab Emtansine
Breast Cancer Therapeutic Procedure
breast cancer

---
https://pgtmsite.files.wordpress.com/2024/01/pertuzumab_position-preliminaire_final.pdf
2014
Canada
drug information
PAX8 Gene Rearrangement
KIT Positive
pertuzumab
NRAS Gene Mutation
SDHB Positive
c-MET Gene Amplification
KRAS Gene Mutation
IDH Gene Family Mutation
Hepatitis C Virus RNA Positive
PAS Positive
FGFR2 Gene Rearrangement
Positive Number
Estrogen Receptor Positive
ANO1 Positive
breast cancer
GNAQ Gene Mutation
FGFR1 Gene Rearrangement
pertuzumab
Human Immunodeficiency Virus Positive
1p/19q Codeletion
HER-2 positive breast cancer
ESR2 Positive
Hepatitis B Virus Surface Antigen Positive
HRAS Gene Mutation
Breast Cancer Therapeutic Procedure
Herero Language
Positive Lymph Node
Positive EBV Test
RET/PTC Rearrangement
FGFR3 Gene Mutation
SDHA Positive
TERT Promoter Mutation
Pertuzumab
MGMT Gene Promoter Methylation
ERG Gene Rearrangement
GNA11 Gene Mutation
Metastatic Malignant Neoplasm in the Breast
breast neoplasms
pertuzumab
ATRX Gene Mutation
ERBB2 Gene Mutation
neoplasm, malignant
Hepatitis B DNA Positive
Hepatitis B Surface Antibody Positive
FGFR3 Gene Rearrangement
BAP1 Gene Mutation
FGFR2 Gene Mutation
PD-L1 Positive
ERBB2 Gene Amplification
CDH1 Gene Mutation
CTNNB1 Gene Mutation
ETV Gene Rearrangement
Progesterone Receptor Positive

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.